Baricitinib (Olumiant®) Thromboembolic Event in Patient Receiving Full-dose Anticoagulation
by Alexis A. Vandehey PharmD, Megan A. Avery 2022 PharmD Candidate, Jennifer A. Esch PharmD BCPS, Jessica S. Thompson APNP
"We describe the case of a 69-year-old male on baricitinib for COVID-19 treatment who developed bilateral deep vein thromboses while on full- dose anticoagulation with apixaban. Patients should be closely monitored for signs of venous thromboembolism while on baricitinib, even while on anticoagulation."
Keywords: Baricitinib, COVID-19 drug treatment, COVID-19, SARS-CoV-2, Cardiovascular Diseases, Drug Labeling, Ethics Committees, Research, Incidence, Public Health, Standard of Care, Venous Thromboembolism, Risk Factors, Arthritis Rheumatoid, Janus Kinases, Thrombosis, Venous Thrombosis, Pulmonary Embolism, Stroke, Heart Disease Risk Factors, Autoimmune Diseases, Communicable Diseases, Anti-Inflammatory Agents, Anticoagulants, Oxygen
Download PDF
2022 July/August Table of Contents
"We describe the case of a 69-year-old male on baricitinib for COVID-19 treatment who developed bilateral deep vein thromboses while on full- dose anticoagulation with apixaban. Patients should be closely monitored for signs of venous thromboembolism while on baricitinib, even while on anticoagulation."
Keywords: Baricitinib, COVID-19 drug treatment, COVID-19, SARS-CoV-2, Cardiovascular Diseases, Drug Labeling, Ethics Committees, Research, Incidence, Public Health, Standard of Care, Venous Thromboembolism, Risk Factors, Arthritis Rheumatoid, Janus Kinases, Thrombosis, Venous Thrombosis, Pulmonary Embolism, Stroke, Heart Disease Risk Factors, Autoimmune Diseases, Communicable Diseases, Anti-Inflammatory Agents, Anticoagulants, Oxygen
Download PDF
2022 July/August Table of Contents